A Phase 2 clinical trial of GDC-0310 for the treatment of pain

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 14 Nov 2017

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

07 Nov 2017 According to a Xenon Pharmaceuticals media release, based on the data from ongoing pre-clinical toxicology studies the company has decided to postpone the initiation of this trial. Future development will be updated once the pre-clinical studies are completed and the final results are analyzed.
03 Aug 2017 According to a Xenon Pharmaceuticals media release, the company plans to initiate this study in the first quarter of 2018.
11 Mar 2017 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com